Abiopharma

🔍 MALLOY JOHN F. (Director)

Company: HUBBELL INC (HUBB)

Report Date: 2026-05-05

Detailed Transactions and Holdings:

• Acquired 341 shares of Common Stock (Direct)
  Date: 2026-05-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 19,426.31 | transaction_form_type: 4 | Footnotes: F1
• Holds 1,818 shares of Directors Deferred Compensation Stock Units (Derivative)
  Date: 2026-05-05 | Code: H | shares_owned_after: 1,817.71 | Footnotes: F2, F3, F3, F4, F4
• Holds 1,867 shares of Directors Deferred Restricted Common Stock Units (Derivative)
  Date: 2026-05-05 | Code: H | shares_owned_after: 1,866.67 | Footnotes: F2, F3, F3, F5, F5

Footnotes:

• F1: Restricted stock grant vesting on date of next regularly scheduled Annual Meeting of Shareholders to be held in 2027.
• F2: Each deferred unit consists of one share of Common Stock credited as units under the Company's Deferred Plan for Directors.
• F3: Deferred units are payable commencing six months following the reporting person's retirement or separation from the Board.
• F4: Balance has been updated to reflect additional stock units credited through reinvested dividends that have been paid on the individual's Directors Deferred Compensation Stock Units.
• F5: Balance has been updated to reflect additional restricted stock units credited through reinvested dividends that have been paid on the individual's Directors Deferred Restricted Common Stock Units.